CANNABINOID DERIVATIVE – CFN Media

Skye Bioscience Completes Enrollment of Phase 1 Clinical Trial of Novel CB1R Agonist, SBI-100 Ophthalmic Emulsion

SKYE COMPLETES DOSING OF FINAL COHORT OF HEALTHY VOLUNTEERS IN STUDY OF…

Ryan Allway
June 12, 2023

Don Kreski

Robin Lefferts

Ryan Allway

Ryan has been a financial writer for more than a decade, covering…

New Interview with Aduro’s Executive Team Sheds Light on Commercialization

Aduro Clean Technologies Inc. (NASDAQ: ADUR) (CSE: ACT) (FSE: 9D5) have begun…

Robin Lefferts
November 26, 2024

Interview with Cardiol Therapeutics’ CEO David Elsley

Cardiol Therapeutics Inc. (Nasdaq: CRDL) (TSX: CRDL) is a life sciences company…

Robin Lefferts
November 26, 2024

Leef Brands Takes the Glass House Model to Extracts

Most investors in the cannabis space are familiar with Glass House Brands…

Robin Lefferts
November 25, 2024

Top News

International Land Alliance Announces Third Quarter Results

SAN DIEGO, CALIFORNIA, Nov. 21, 2024 (GLOBE NEWSWIRE) — International Land…

Ryan Allway
November 21, 2024